New Jersey, Pennsylvania, Rhode Island – UHC Genetic and Molecular Lab Testing Notification Requirement

April 2019 ~

UnitedHealthcare (UHC) will soon require providers in New Jersey, Rhode Island, and Pennsylvania to complete the notification/prior authorization process for genetic and molecular testing performed in an outpatient setting.

States soon to be included in this requirement will include:

  • Effective April 1: New Jersey, Rhode Island
  • Effective July 1: Pennsylvania

NOTE: All UnitedHealthcare Medicare and Medicare Advantage plan members, including Dual Special Needs Plans (DSNP) members, are not included in these requirements.

 Source(s): UnitedHealthcare Network Bulletin April 2019;

 

 

 

AdvantEdge
AdvantEdge